The University of Cambridge is launching its second enterprise fund for the 2013-14 tax year to support the University’s commercialisation efforts with the target of raising £1.5m ($2.2m).

The first fund made three investments (Cambridge CMOS Sensors, DefiniGEN, and Inotec AMD) during November last year. Then last month, it took part in a $2.5m series A for Sphere Fluidics, a Cambridge life sciences spin-out, led by private equity firm 24Haymarket with participation from the Royal Society and a number of others.  Cambridge expects the first fund to be fully invested within the coming months.

The University has produced 12 companies valued at over $1bn, two of which, microprocessor manufacturer ARM and HP-owned software firm Autonomy, are valued in excess of $10bn. Most of the companies are either founded through tech transfer activity, or by Cambridge graduates.

“The response from University alumni and friends to…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?